Back to MDT Overview
NYQ · Valuation Lab
MDT
Medtronic plc.
Last$85.99
Market cap—
EV/EBITDA13.0x
Intrinsic value
$187257718747.66
MoS +100.0% · Undervalued
Assuming 12.7% FCF margin and 9.9% Y1–5 growth.
Upside to price
EV (DCF)207.2B
Terminal share75%
Expected IV$185820882487.80
Probability weights
Projected free cash flows
Stage FCF path with present values · terminal 75% of EV
PV of stage FCFs52.7B
PV of terminal value154.5B
Enterprise value207.2B
Net cash / (debt)-19.9B
Equity value187.3B
Intrinsic value / share$187257718747.66
| Year | Revenue | FCF | PV | DF |
|---|---|---|---|---|
| Y1 | 40B | 5.1B | 4.8B | 94.3% |
| Y2 | 43.9B | 5.6B | 5B | 89.0% |
| Y3 | 48.3B | 6.1B | 5.1B | 84.0% |
| Y4 | 53B | 6.7B | 5.3B | 79.2% |
| Y5 | 58.3B | 7.4B | 5.5B | 74.7% |
| Y6 | 61.2B | 7.8B | 5.5B | 70.5% |
| Y7 | 64.3B | 8.2B | 5.4B | 66.5% |
| Y8 | 67.5B | 8.6B | 5.4B | 62.7% |
| Y9 | 70.9B | 9B | 5.3B | 59.2% |
| Y10 | 74.4B | 9.4B | 5.3B | 55.8% |
| Terminal | — | — | 154.5B | — |
Educational DCF model only — not financial advice. Terminal value and assumptions dominate results; verify filings and run your own diligence.